Tiny but mighty: Possible roles of bacterial extracellular vesicles in gut-liver crosstalk for non-alcoholic fatty liver disease

被引:2
|
作者
Shao, Li [1 ,2 ]
Shi, Junping [3 ]
Fan, Xiaohui [4 ,5 ]
机构
[1] Hangzhou Normal Univ, Affiliated Hosp, Sch Clin Med, Hangzhou, Peoples R China
[2] Hangzhou Normal Univ, Inst Hepatol & Metab Dis, Hangzhou, Peoples R China
[3] Hangzhou Normal Univ, Affiliated Hosp, Dept Hepatol, Hangzhou, Peoples R China
[4] Zhejiang Univ, Pharmaceut Informat Inst, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China
[5] Westlake Lab Life Sci & Biomed, Hangzhou, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
bacterial extracellular vesicle; gut-liver axis; NAFLD; OUTER-MEMBRANE VESICLES; PROTECT; CELL; DNA; MACROPHAGES; EXPRESSION; PATHOGENS; IMMUNITY;
D O I
10.1002/ctd2.115
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) with an increasing incidence is one of the leading causes for liver transplantation and cancer, whereas understandings on the onset and development of this disease are quite limited. Nowadays, gut microbial dysregulation has been proposed to play a critical role in the immune-metabolic disorders in NAFLD patients via gut-liver axis. Although definitive crosstalk between gut and liver has not been thoroughly depicted, the nanosized bacterial extracellular vesicles (bEVs) capable of transporting multiple kinds of molecules to distant organs of host in intact form via system circulation act as major mediators in host-bacterial interactions. A recent review has confirmed the associations between bEVs and NAFLD features such as insulin resistance and liver inflammation, whereas the mechanisms involved have not been elucidated. Considering that gut-liver crosstalk is the main pathway through which bEVs take part in NAFLD pathogenesis, we summarize the recent findings of bEVs in gut-liver crosstalk by modulating the reshape of gut microbial system, host intestinal barrier integrity, host immune responses and metabolic homeostasis, as well as the potential roles of bEVs in regulating NAFLD progression. Metabolites and cytokines from liver confer environmental stress to gut microbiota. Under the environmental stress, bacteria secrete extracellular vesicles (bEVs) to help survival. The secreted bEVs then mediate gut microbial remodelling and intestinal barrier dysfunction. Via impaired intestinal barrier, bEVs enter host circulation and generate direct crosstalk with cells in liver. image
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Alcoholic liver disease and the gut-liver axis
    Szabo, Gyongyi
    Bala, Shashi
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (11) : 1321 - 1329
  • [42] Roles of Gut-Derived Secretory Factors in the Pathogenesis of Non-Alcoholic Fatty Liver Disease and Their Possible Clinical Applications
    Okubo, Hirofumi
    Kushiyama, Akifumi
    Nakatsu, Yusuke
    Yamamotoya, Takeshi
    Matsunaga, Yasuka
    Fujishiro, Midori
    Sakoda, Hideyuki
    Ohno, Haruya
    Yoneda, Masayasu
    Asano, Tomoichiro
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [43] THE PATHOLOGICAL PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE CORRELATES WITH GUT MICROBIOTA COMPOSITION IN MICE: FROM NON-ALCOHOLIC FATTY LIVER TO NON-ALCOHOLIC STEATOHEPATITIS
    Peng, J.
    Huang, F.
    Li, X.
    Chen, L.
    Feng, Q.
    Hu, Y.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S155 - S157
  • [44] The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement
    Ji, Yun
    Yin, Yue
    Sun, Lijun
    Zhang, Weizhen
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [45] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [46] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    [J]. PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [47] The liver X receptor: A master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease
    Ducheix, Simon
    Montagner, Alexandra
    Theodorou, Vassilia
    Ferrier, Laurent
    Guillou, Herve
    [J]. BIOCHEMICAL PHARMACOLOGY, 2013, 86 (01) : 96 - 105
  • [48] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    [J]. CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [49] Non-alcoholic fatty liver disease
    Smith, Briohny W.
    Adams, Leon A.
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (03) : 97 - 113
  • [50] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    [J]. BMC MEDICINE, 2017, 15